Treatment of Fatal Disseminated Vaccinia Virus Infection in Immunosuppressed Mice

References

1. Dixon O. J., Sidwell R. W., Miller F. A., Sloan B. J. 1968; Antiviral activity of 9-β-d arabinofurano-syladenine. V. Activity against intracerebral vaccinia virus infections in mice. Antimicrobial Agents and Chemotherapy 1968:172–179
   [Google Scholar]
2. Fulginiti V. A., Kempe C. H., Hathaway W. F., Pearlman D. S., Siever O. F. Jun, Eller J. J., Joyner J. J. Sen, Robinson A. 1968; Progressive vaccinia in immunologically deficient individuals. In Immunologic Deficiency Diseases in Man. Birth Defects Original Article Series vol IV pp 139–151 Edited by Bergsma D., Good R. A. New York: National Foundation;
   [Google Scholar]
3. Levey R. H. 1970; Influences of antilymphocyte serum on cell-mediated and antibody-mediated responses. Federation Proceedings 29:156
   [Google Scholar]
4. Levey F. H., Medawar P. B. 1966; Nature and mode of action of antilymphocytic antiserum. Proceedings of the National Academy of Sciences of the United States of America 56:1130–1137
   [Google Scholar]
5. Levine A. S., Schimpff S. C., Graw R. G. Jun, Young R. C. 1974; Hematologic malignancies and other marrow failure states: progress in the management of complicating infections. Seminars in Hematology 11:141–202
   [Google Scholar]
6. Montgomerie J. Z., Becroft D. M. O., Croxson M. C., Doak P. B., North J. D. K. 1969; HerpeS-simpleX-virus infection after renal transplantation. Lancet ii:867–871
   [Google Scholar]
7. Sloan B. J., Miller F. A., Ehrlich J., Mclean I. W., Machamer H. E. 1968; Antiviral activity of 9-B-D arabinofuranosyladenine. IV. Activity against intracerebral herpes simplex virus infections in mice. Antimicrobial Agents and Chemotherapy 1968:161–171
   [Google Scholar]
8. Stevens D. A., Jordan G. W., Waddell T. F., Merigan T. C. 1973; Adverse effect of cytosine arabinoside on disseminated zoster in a controlled trial. New England Journal of Medicine 289:873–878
   [Google Scholar]
9. St Geme J. W. Jun, Prince J. T., Burke B. A., Good R. A., Krivit W. 1965; Impaired cellular resistance to herpes-simplex-virus in Wiskott-Aldrich syndrome. New England Journal of Medicine 273:229–234
   [Google Scholar]
10. Whitley R. J., Ch’len L. T., Dolin R., Galasso G. J., Alford C. A. Jun The Collaborative Study Group 1976; Adenine arabinoside therapy of herpes zoster in the immunosuppressed. New England Journal of Medicine 294:1193–1199
    [Google Scholar]
11. Worthington M. 1973; Mechanism of recovery from systemic infection with vaccinia virus. III. Effects of antithymocyte serum. Journal of Infectious Diseases 127:518–524
    [Google Scholar]